Papers: 10.1186/1756-9966-29-58

https://doi.org/10.1186/1756-9966-29-58

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

Cited by: 49
Author(s): Fotios Loupakis, Emilio Bria, Vanja Vaccaro, Federica Cuppone, Michèle Milella, Paolo Carlini, Chiara Cremolini, Lisa Salvatore, Alfredo Falcone, Paola Muti, Isabella Sperduti, Diana Giannarelli, Francesco Cognetti
Published: about 15 years ago

Software Mentions 1